Get the Stockscreener App
2.86
0.35%
-0.01
Why is Galmed Pharmaceuticals Ltd (GLMD) Stock down?
We've noticed a 5.41% decline in Galmed Pharmaceuticals Ltd (GLMD) stock during the 2024-11-21 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
21 Nov, 2023:
Galmed Pharmaceuticals Ltd Stock (GLMD) dropped by 17.08% from $0.4343 to $0.3601 in the trading on Tuesday November 21, 2023. The reason why GLMD stock down today is due to the news of delay in sclerosing cholangitis Phase 2a study. Galmed Pharmaceuticals has recently made an announcement regarding the postponement of its highly anticipated Primary Sclerosing Cholangitis (PSC) Phase 2a study. Due to this unexpected delay, the commencement of the trial will be delayed by approximately six to nine months. This unforeseen setback has prompted Galmed Pharmaceuticals to reassess and adjust their plans accordingly.
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):